APA (7th ed.) Citation

Vermathen, M., Paul, L. E. H., Diserens, G., Vermathen, P., & Furrer, J. (2015). 1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Vermathen, Martina, Lydia E H. Paul, Gaëlle Diserens, Peter Vermathen, and Julien Furrer. 1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug. Public Library of Science (PLoS), 2015.

MLA (8th ed.) Citation

Vermathen, Martina, et al. 1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug. Public Library of Science (PLoS), 2015.